Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Alopecia Market Outlook

The global alopecia market size attained a value of USD 3.58 billion in 2023. The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses. The market is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032 to attain a value of USD 7.53 billion by 2032.

Global Alopecia Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Properties and Applications

There are many different kinds of alopecia, each with a distinct cause. As is prevalent in male pattern baldness, alopecia can be located at the front and top of the head. It may be patchy as in an alopecia areata disorder. The alopecia market can be divided on the basis of segments like disease type, drug type, route of administration, gender, and distribution channel.

Global Alopecia Market By Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The global alopecia market can be broadly categorised on the basis of disease type into:

  • Androgenic Alopecia
  • Alopecia Areata
  • Ciatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis

The industry can be divided on the basis of drug type as:

  • Minoxidil
  • Finasteride
  • Others

The global alopecia market can be categorised based on route of administration as:

  • Oral
  • Topical
  • Injectable

The industry can be divided based on gender as:

  • Males
  • Females

The global alopecia market can be divided on the basis of the distribution channel as:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of alopecia like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Global Alopecia Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Alopecia Market Analysis

It is expected that the occurrence of Polycystic Ovary Syndrome (PCOS), cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses will drive the global alopecia market. Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are regarded as powerful triggers for alopecia. While the precise causative factors stay unknown, genetic factors are associated with several instances. Increasing disposable earnings and increasing emphasis on aesthetic appearances are anticipated to contribute to the demand for therapy of alopecia. Hormonal imbalance and ageing accelerate the growth of hair loss instances, further aiding the global alopecia market growth. The overall increase in the geriatric population and rising customer consciousness of therapy alternatives are also anticipated to have a positive impact on the global alopecia market in the following years. During the forecast period, the product development of new therapeutic alternatives is anticipated to drive the industry growth. Other factors driving the industry include the introduction of fast-acting JAK inhibitors, the development of techniques to boost hair growth using human pluripotent stem cells, and PRP therapy.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global alopecia market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Cipla Ltd.
  • Capillus LLC
  • Freedom Laser Therapy, Inc.
  • Apira Science, Inc.
  • HairMax (Lexington Intl., LLC)
  • Follica, Inc.
  • Incyte Corporation
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Disease Type
  • Treatment
  • Route of Administration
  • Gender
  • Distribution Channel
  • End User
  • Region
Breakup by Disease Type
  • Androgenic Alopecia
  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Others
Breakup by Treatment
  • Localized Therapies
  • Systemic Therapies
  • Medical Devices
  • Herbal Treatment
  • Others
Breakup by Route of Administration
  • Oral
  • Topical
  • Parenteral
Breakup by Gender
  • Males
  • Female
Breakup by Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
Breakup by End User
  • Hospitals
  • Healthcare and Dermatology Centers
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cipla Ltd.
  • Capillus LLC
  • Freedom Laser Therapy, Inc.
  • Apira Science, Inc.
  • HairMax (Lexington Intl., LLC)
  • Follica, Inc.
  • Incyte Corporation
  • Novartis International AG
  • Sanofi S.A.
  • Merck & Co. Inc.
  • Gerolymatos International SA
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • WOCKHARDT
  • Teva Pharmaceuticals USA, Inc.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

Globally, alopecia market reached a value of USD 3.58 billion in 2023.

The market is projected to expand at a CAGR of 8.6% from 2024 to 2032, growing to USD 7.53 billion by 2032.

The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses.

Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

The major disease types of alopecia in the market are androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis.

The significant drug types in the industry are minoxidil and finasteride, among others.

The leading routes of administration in the market are oral, topical, and injectable.

The major gender segments in the industry are males and females.

The significant distribution channels in the market are hospitals, retail pharmacies, and online pharmacies.

The major players in the industry are Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124